JP2016529908A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529908A5 JP2016529908A5 JP2016539674A JP2016539674A JP2016529908A5 JP 2016529908 A5 JP2016529908 A5 JP 2016529908A5 JP 2016539674 A JP2016539674 A JP 2016539674A JP 2016539674 A JP2016539674 A JP 2016539674A JP 2016529908 A5 JP2016529908 A5 JP 2016529908A5
- Authority
- JP
- Japan
- Prior art keywords
- mvp
- solution
- molecule
- binding
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361875729P | 2013-09-10 | 2013-09-10 | |
| US61/875,729 | 2013-09-10 | ||
| PCT/IB2014/064352 WO2015036917A2 (en) | 2013-09-10 | 2014-09-09 | Methods and kits for quantifying the removal of mock virus particles from a purified solution |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019118216A Division JP2019195333A (ja) | 2013-09-10 | 2019-06-26 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016529908A JP2016529908A (ja) | 2016-09-29 |
| JP2016529908A5 true JP2016529908A5 (enExample) | 2017-11-16 |
| JP6549126B2 JP6549126B2 (ja) | 2019-07-31 |
Family
ID=52625972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016539674A Active JP6549126B2 (ja) | 2013-09-10 | 2014-09-09 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
| JP2019118216A Withdrawn JP2019195333A (ja) | 2013-09-10 | 2019-06-26 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019118216A Withdrawn JP2019195333A (ja) | 2013-09-10 | 2019-06-26 | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US9632087B2 (enExample) |
| EP (1) | EP3044339B1 (enExample) |
| JP (2) | JP6549126B2 (enExample) |
| CN (1) | CN105899684B (enExample) |
| AU (3) | AU2014320015B2 (enExample) |
| DK (1) | DK3044339T3 (enExample) |
| WO (1) | WO2015036917A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015036917A2 (en) * | 2013-09-10 | 2015-03-19 | MockV Solutions | Methods and kits for quantifying the removal of mock virus particles from a purified solution |
| US20220026440A1 (en) * | 2018-11-14 | 2022-01-27 | Nissan Chemical Corporation | Container and method for storing, pretreating, and analyzing biomaterial |
| EP4112735A4 (en) * | 2020-02-28 | 2023-09-06 | Asahi Kasei Medical Co., Ltd. | Method for evaluating viral clearance performance |
| US12203914B2 (en) | 2020-11-12 | 2025-01-21 | Sartorius Bioanalytical Instruments, Inc. | Viral clearance evaluation for biological medical product preparation processes |
| CN118465260B (zh) * | 2024-07-09 | 2024-10-15 | 浙江康佰裕生物科技有限公司 | 测定逆转录病毒包膜蛋白elisa方法的建立及应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988002026A1 (en) * | 1986-09-08 | 1988-03-24 | Applied Biotechnology, Inc. | Empty viral capsid vaccines |
| US5173399A (en) * | 1988-06-10 | 1992-12-22 | Abbott Laboratories | Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests |
| AU631159B2 (en) * | 1988-11-14 | 1992-11-19 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Parvovirus capsids |
| WO1993000103A1 (en) * | 1991-06-21 | 1993-01-07 | The Wistar Institute Of Anatomy And Biology | Chimeric envelope proteins for viral targeting |
| US5814442A (en) * | 1994-06-10 | 1998-09-29 | Georgetown University | Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid |
| WO2001072964A2 (en) | 2000-03-27 | 2001-10-04 | Smithkline Beecham Corporation | Detection of viable agents |
| EP1170367A1 (en) * | 2000-06-27 | 2002-01-09 | Bayer Ag | BVDV virus-like particles |
| US20040002058A1 (en) * | 2001-06-21 | 2004-01-01 | Uab Research Foundation | Chimeric capsid proteins and uses thereof |
| US7041444B2 (en) * | 2003-01-14 | 2006-05-09 | Washington University | Murine calicivirus |
| EP2055316A1 (en) * | 2003-09-09 | 2009-05-06 | VIRxSYS Corporation | Lentivirus vector-based approaches for generating an immune response to HIV in humans |
| US20070184068A1 (en) * | 2005-12-14 | 2007-08-09 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| WO2007146197A1 (en) * | 2006-06-09 | 2007-12-21 | Xing-Xiang Li | Methods and reagents for virus isolation and detection |
| US20080132688A1 (en) * | 2006-09-22 | 2008-06-05 | Amgen Inc. | Methods for Removing Viral Contaminants During Protein Purification |
| EP2198020B1 (en) * | 2007-09-14 | 2016-04-13 | Institut Pasteur | Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| GB0803068D0 (en) * | 2008-02-20 | 2008-03-26 | Health Prot Agency | Cross-linked biological indicator |
| TW201028433A (en) * | 2008-10-20 | 2010-08-01 | Abbott Lab | Viral inactivation during purification of antibodies |
| US9744228B2 (en) * | 2010-04-07 | 2017-08-29 | Norvartis Ag | Method for generating a parvovirus B19 virus-like particle |
| WO2011130119A2 (en) | 2010-04-14 | 2011-10-20 | Millipore Corporation | Methods of producing high titer, high purity virus stocks and methods of use thereof |
| WO2015036917A2 (en) * | 2013-09-10 | 2015-03-19 | MockV Solutions | Methods and kits for quantifying the removal of mock virus particles from a purified solution |
-
2014
- 2014-09-09 WO PCT/IB2014/064352 patent/WO2015036917A2/en not_active Ceased
- 2014-09-09 CN CN201480049583.5A patent/CN105899684B/zh active Active
- 2014-09-09 JP JP2016539674A patent/JP6549126B2/ja active Active
- 2014-09-09 AU AU2014320015A patent/AU2014320015B2/en active Active
- 2014-09-09 EP EP14843784.1A patent/EP3044339B1/en active Active
- 2014-09-09 DK DK14843784.1T patent/DK3044339T3/da active
- 2014-09-09 US US14/481,364 patent/US9632087B2/en active Active
-
2017
- 2017-03-11 US US15/456,487 patent/US10309963B2/en active Active
-
2019
- 2019-04-17 US US16/386,327 patent/US11754565B2/en active Active
- 2019-06-26 JP JP2019118216A patent/JP2019195333A/ja not_active Withdrawn
-
2021
- 2021-01-27 AU AU2021200484A patent/AU2021200484B2/en active Active
-
2023
- 2023-06-21 US US18/212,606 patent/US20240085419A1/en active Pending
- 2023-09-12 AU AU2023229501A patent/AU2023229501B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7210518B2 (ja) | 組み換えバクテリオファージを使用する、微生物の迅速検出のための方法及びシステム | |
| Guthmiller et al. | An efficient method to generate monoclonal antibodies from human B cells | |
| Maramorosch et al. | Methods in Virology: Volume V | |
| Anzenbacher et al. | Metabolism of drugs and other xenobiotics | |
| US12006531B2 (en) | Methods and systems for rapid detection of microorganisms using infectious agents | |
| Castello et al. | Comprehensive identification of RNA-binding proteins by RNA interactome capture | |
| JP2016529908A5 (enExample) | ||
| Fiebig et al. | Distribution of porcine cytomegalovirus in infected donor pigs and in baboon recipients of pig heart transplantation | |
| CN103764827B (zh) | 可用于分离和／或纯化核酸的试剂 | |
| CN103890176A (zh) | 制备生物材料的方法 | |
| JP2019195333A (ja) | 生成された溶液からのモックウイルス粒子の除去を定量するための方法およびキット | |
| WO2011103163A2 (en) | Nucleic acid extraction from complex matrices | |
| CA2967008A1 (en) | Chaotrope- and volatile-free method for purifying nucleic acids from plasma | |
| Sousa et al. | A novel method for human hematopoietic stem/progenitor cell isolation from umbilical cord blood based on immunoaffinity aqueous two-phase partitioning | |
| JP2014523405A5 (enExample) | ||
| Keck et al. | Comparison of biosafety and diagnostic utility of biosample collection cards | |
| Morao et al. | Cell type-specific profiling of chromatin modifications and associated proteins | |
| Luitjens et al. | Production and purification of recombinant proteins | |
| Wendlandt et al. | Getting hold of the tobamovirus particle—Why and how? Purification routes over time and a new customizable approach | |
| Mardini et al. | Hidden pitfalls of using onion pollen in molecular research | |
| RU2677336C2 (ru) | Способ получения вирусоподобных частиц папилломавируса человека | |
| CN110818773B (zh) | 纯化非人动物羊水中活性物质的方法 | |
| CN106754753A (zh) | 病毒培养方法 | |
| Ding et al. | Chromatin immunoprecipitation assay of brain tissues using Percoll gradient-purified nuclei | |
| Liu et al. | Inhibition of SARS-CoV-2 infection in cellular systems using engineered trimeric receptor-binding domain of spike protein |